Skip to main content

Table 3 Univariate analyses of risk factors for death associated with Acinetobacter baumannii infection

From: The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumanniiinfection

Variable

Deaths (n = 17)

Survivors (n = 32)

Odds ratio (95%CI)

p

 

n (%)

n (%)

  

Male sex

9 (53)

20 (63)

0.68 (0.21 – 2.22)

0.52

Age ( each 10 years)

10 (59)

12 (38)

1.08 (0.74 – 1.55)

0.70

Liver transplant

14 (82)

11 (34)

8.91 (2.10 – 37.8)

0.003

Infection acquired in the ICU

15 (88)

9 (28)

19.2 (3.63 – 101.3)

0.001

Previous use of any antibiotic a

5 (36)

17 (65)

0.29 (0.08 – 1.15)

0.08

Previous use of carbapenem a

4 (29)

7 (27)

1.09 (0.26 – 4.62)

0.91

Extra-urinary site of infection

17 (100)

18 (56)

Undefined

<0.001

 Primary bacteremia

7 (41)

10 (31)

 Pneumonia

7 (41)

6 (19)

 Surgical site infection

3 (18)

2 (6)

Bacteremia b

11 (65)

17 (53)

1.43 (0.42 – 4.81)

0.57

Central venous catheter

16 (94)

15 (47)

18.1 (2.14 – 153.6)

0.008

Mechanical ventilation

15 (88)

10 (31)

16.5 (3.16 – 86.3)

0.001

Serum creatinine (for each 100 μmol/L) c

170 (80– 230)

270 (110 – 460)

0.68 (0.44 – 1.06)

0.10

Hemodialysis

6 (35)

6 (19)

2.36 (0.62 – 8.97)

0.21

Therapy for acute graft rejection

1 (6)

11 (34)

0.17 (0.03 – 0.88)

0.03

Septic shock

9 (53)

6 (19)

4.88 (1,33 – 17.9)

0.02

Appropriate empiric therapy

8 (47)

21 (66)

0.47 (0.14 – 1.55)

0.21

Resistance to carbapenem

8 (47)

10 (30)

1.96 (0.58 – 6.56)

0.28

  1. ICU – intensive care unit; CI = confidence interval; a Data available for 40 cases; b includes 11 cases of secondary bacteremia; c median(interquartile range).